Plerixafor, CXCR4 antagonist (TBI2864)
$117.00 – $360.00
CXCR4 antagonist
| SKU | Stock | SIZE (mg) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| TBI2864-10MG | Yes | 10 MG | $117.00 | |||
| TBI2864-50MG | Yes | 50 MG | $360.00 |
- Description
- Terms
- Additional information
- Documents
- Reviews (0)
Description
Product Details
Formal Name: 1,1’-[1,4-Phenylenebis-(methylene)]-bis(1,4,8,11-tetraazacyclotetradecane), octahydrochloride
Alternate Names: AMD3100
Molecular Formula: C28H54N8·8HCl
Formula Weight: 794.5
CAS Number: 110078-46-1
Purity: >98%
Formulation: Powder
Solubility: Soluble in Water (up to 25 mg/ml)
Storage: -20°C
Stability: ≥ 1 year.
Applications
CXCR4 antagonist
Functions
Plerixafor is a highly selective CXCR4 antagonist (IC50 = 20-130 nM). Originally investigated as an HIV replication inhibitor. Plerixafor has been investigated for the treatment autoimmune diseases and various cancers. Clinically useful for the mobilization of hematopoietic stem cells in the treatment of blood cancers.
Application Procedures
First dissolved in Water (up to 25 mg/ml), then diluted to aqueous buffer. Solutions in distilled water may be stored at -20°C for up to 2 months.
Additional information
| SIZE (mg) | 10 MG, 50 MG |
|---|
Be the first to review “Plerixafor, CXCR4 antagonist (TBI2864)”
You must be logged in to post a review.
Reviews
There are no reviews yet.